Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis
Authors:
- Ovidiu TatarOTOvidiu Tatar
- Erika ThompsonETErika Thompson
- Anila NazANAnila Naz
- Samara PerezSamara Perez
- Gilla K. ShapiroGSGilla K. Shapiro
- Kristina WadeKWKristina Wade
- Gregory ZimetGZGregory Zimet
- Vladimir GilcaVGVladimir Gilca
- Monika JandaMJMonika Janda
- Jessica KahnJKJessica Kahn
- Ellen DaleyEDEllen Daley
- Zeev RosbergerZRZeev Rosberger
- 1 November 2018
- journal article
- review article
- Published by Elsevier in Preventive Medicine
- Vol. 116, 40-50
Abstract
No abstract availableKeywords
Funding Information
- Canadian Cancer Society Research Institute (704036)
This publication has 49 references indexed in Scilit:
- Human papillomavirus and cervical cancerThe Lancet, 2013
- Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2012
- Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trialThe Lancet Oncology, 2012
- Mapping the Mixed Methods–Mixed Research Synthesis TerrainJournal of Mixed Methods Research, 2011
- Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trialThe Lancet Oncology, 2010
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young womenThe Lancet, 2009
- HPV Screening for Cervical Cancer in Rural IndiaNew England Journal of Medicine, 2009
- Preferences for Human Papillomavirus Testing with Routine Cervical Cancer Screening in Diverse Older WomenJournal of General Internal Medicine, 2008
- Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trialThe Lancet, 2007
- Human Papillomavirus and Papanicolaou Tests to Screen for Cervical CancerNew England Journal of Medicine, 2007